Page 384 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

345
4. LES NORMOLIPÉMIANTS

HARTMAN G.D. et al. “3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
9.The synthesis and biological évaluation of novel simvastatin analogs" (1992)
J Med Chem, 35 (21), 3183-3221.
MIYACHI N. et al. “A novel synthetic method of HMG-CoA reductase inhibitor NK-104
via a hydroboration-cross coupling sequence" (1993) Tetrahedron Lett, 34 (51),
8227-8270.
ANSARI M.H. et al. "Synthesis of optically active t-butyl (3fl,5S)3,5-isopropylidenedi-
oxy-6-heptynoate through Baker's yeast réduction of methyl 3-oxo-4-pentynoate"
(1993) Tetrahedron Lett 34 (51), 8271-8274.
Fluvastatin (1992) Drugs Future, 17 (9), 847.
YUAN J. et al. "Effects of fluvastatin (XU62-320) an HMG-CoA reductase inhibitor, on
the distribution of low density lipoprotein subspecies in humans (1991)
Atherosclerosis 87, 147-157.
TSE F.L.S. "Disposition of fluvastatin, an inhibitor of HMG-Coa reductase, in mouse,
rat, dog and monkey" (1990) Biopharmaceutics and Drug Disp, 11, 519-531.
KARANEWSKY D.S. et al. “Phosphonous-containing inhibitors of HMG-CoA reduc­
tase ; 4- [(2-arylethyl) hydroxyphosphinyl]-3-hydroxybutanoic acids A new class of
cell-sensitive inhibitors od cholestérol biosynthesis" (1990) J Med Chem, 33 (11),
2952-2956.
Dalvastatin (1992) Drugs Future, 17 (5), 377-379.
REGAN J.R. et al. “Biological effects of a 6- [2- [2- (4-fluoro-3-methylphenyl)-4-substi-
tuted cyclohex-1 -en-1 -yl] ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one"
(1992) Eur J Med Chem, 27 (7), 735-742.
SLISKOVIC D.R. et al. "Inhibitors of cholestérol biosynthesis : 6-trans-6- [2- (2-N-hete-
roaryl-3,5-disubstituted-pyrazol-4-yl) ethyl/ethenyl] tetrahydro-4-hydroxy-2H-pyran-
2-ones" (1992) J Med Chem, 35 (11), 2095-2103.
ANGEBAUER R. et al. "Rivastatin (Bay W 6228) : a new génération HMG-CoA reduc­
tase inhibitor" (1993) Communications des Lab. BAYER A G, Pharma. Research
Center, D-5600 Wuppertal 1, FRG.

AUTRES INHIBITEURS DU MÉTABOLISME DU CHOLESTÉROL
Inhibiteurs de l'ACAT
GAMMIL R.B. "Antiatherosclerotic Agents : a structurally novel bivalent inhibitor c
ACAT with systemic activy" (1990) J Med Chem, 33 (10), 2685-2687.
BILLHEIMER J.T. et al. "ACAT inhibitors : potential antihypertensive agents" (1991)
Current Drugs : Antiatherosclerotic Agents.
LARSEN S.D. et al. "Pyrimidinediones : synthesis and hypocholestérolémie activity of
6,7-dihydro-4H-pyrazolo1,5-a]pyrrolo[3,4-c()pyrimidine-2,5-diones, novel inhibitors
of ACAT" (1991 ) J Med Chem, 34 (5), 1721 -1727.
"Enzymes as targets for hypolipidémie drug design. Cholestérol absorption inhibitors :
ACAT inhibitors, cholestérol esterase inhibitors” (1992) Annu Drug Data Hep, 14
(suppl 1), S1-S28.
WOODS WANNAMAKER M. et al. “N-(1-oxododecyl)-4a,10-dimethyl-8-aza-trans-
decan-3p-ol : A potent compétitive inhibitor of 2,3-oxidosqualene cyclase (1992) J
Med Chem, 35 (19), 3581-3583.